171 related articles for article (PubMed ID: 20418655)
1. Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods.
Chiappori A; Villalta D; Bossert I; Ceresola EM; Lanaro D; Schiavo M; Bagnasco M; Pesce G
J Endocrinol Invest; 2010 Mar; 33(3):197-201. PubMed ID: 20418655
[TBL] [Abstract][Full Text] [Related]
2. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
[TBL] [Abstract][Full Text] [Related]
3. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
4. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
5. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three competitive immunoassays for measurement of TSH receptor antibodies in patients with Graves' disease.
Doroudian S; Pedersen IB; Knudsen CS; Handberg A; Andersen SL
Scand J Clin Lab Invest; 2017 Nov; 77(7):535-540. PubMed ID: 28737965
[TBL] [Abstract][Full Text] [Related]
7. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
8. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
9. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.
Tozzoli R; Bagnasco M; Giavarina D; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):107-13. PubMed ID: 22776786
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith.
Kamijo K; Ishikawa K; Tanaka M
Endocr J; 2005 Oct; 52(5):525-9. PubMed ID: 16284428
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease in clinical perspective.
Ehlers M; Schott M; Allelein S
Front Biosci (Landmark Ed); 2019 Jan; 24(1):35-47. PubMed ID: 30468646
[TBL] [Abstract][Full Text] [Related]
12. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
Sawicka N; Sowiński J
Endokrynol Pol; 2012; 63(1):10-3. PubMed ID: 22378091
[TBL] [Abstract][Full Text] [Related]
13. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
14. Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays.
Zöphel K; Roggenbuck D; Wunderlich G; Schott M
Horm Metab Res; 2010 Nov; 42(12):900-2. PubMed ID: 20925015
[TBL] [Abstract][Full Text] [Related]
15. Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
Eur J Endocrinol; 2004 Oct; 151(4):467-74. PubMed ID: 15476447
[TBL] [Abstract][Full Text] [Related]
16. Estimation of serum TSH receptor autoantibody concentration and affinity.
Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
[TBL] [Abstract][Full Text] [Related]
17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
18. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.
Dunkelmann S; Wolf R; Koch A; Kittner C; Groth P; Schuemichen C
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1428-34. PubMed ID: 15221291
[TBL] [Abstract][Full Text] [Related]
19. A novel third-generation TSH receptor antibody (TRAb) enzyme-linked immunosorbent assay based on a murine monoclonal TSH receptor-binding antibody.
Roggenbuck JJ; Veiczi M; Conrad K; Schierack P; Wunderlich G; Kotzerke J; Roggenbuck D; Zöphel K
Immunol Res; 2018 Dec; 66(6):768-776. PubMed ID: 30684216
[TBL] [Abstract][Full Text] [Related]
20. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
